Related Experiment Videos

Anticoagulation therapy in children

Shoshana Revel-Vilk1, Anthony K C Chan

  • 1Pediatric Hematology/ Oncology Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.

Seminars in Thrombosis and Hemostasis
|October 1, 2003
PubMed

Insights

Pediatric thromboembolic events (TEs) are rare but serious, especially in vulnerable children. Differences in hemostasis impact treatment responses, necessitating pediatric-specific anticoagulant research.

Area of Science:

  • Pediatric Hematology
  • Thrombosis and Hemostasis

Background:

  • Thromboembolic events (TEs) are increasingly recognized causes of morbidity and mortality in children.
  • Children with serious conditions like congenital heart disease or cancer, and neonates, infants, and adolescents are at higher risk.
  • Central venous lines and intra-arterial catheters are significant risk factors for pediatric TEs.

Purpose of the Study:

  • To examine the impact of the developmental hemostatic system on anticoagulant responses in children.
  • To highlight the differences between pediatric and adult hemostasis and their implications for thrombosis and treatment.

Main Methods:

  • Review of current literature on pediatric thromboembolism.
  • Analysis of hemostatic differences between pediatric and adult populations.
  • Evaluation of commonly used anticoagulants in children (unfractionated heparin, low-molecular-weight heparins, warfarin).

Main Results:

  • Pediatric hemostasis differs significantly from adult hemostasis, affecting thrombotic processes and anticoagulant efficacy.
  • Established anticoagulant therapies in children are often extrapolated from adult studies.
  • Limited experience exists with novel antithrombotic agents in pediatric populations.

Conclusions:

  • Optimal anticoagulant therapy for pediatric thromboembolism requires further investigation.
  • Well-designed prospective trials are essential to establish evidence-based treatment guidelines for children.
  • Addressing the unique hemostatic characteristics of children is crucial for effective TEs management.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...